共 43 条
[1]
Fredholm B.B., Battig K., Holmen J., Et al., Actions of caffeine in the brain with special reference to factors that contribute to its widespread use, Pharmacol Rev, 51, pp. 83-133, (1999)
[2]
Aden U., Methylxanthines During Pregnancy and Early Postnatal Life, Methylxanthines, pp. 373-389, (2010)
[3]
Moura-Nunes N., Farah A., Caffeine Consumption and Health, (2012)
[4]
Grosso L.M., Bracken M.B., Caffeine metabolism, genetics, and perinatal outcomes: A review of exposure assessment considerations during pregnancy, Ann Epidemiol, 15, pp. 460-466, (2005)
[5]
Tsutsumi K., Kotegawa T., Matsuki S., Et al., The effect of pregnancy on cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activities in humans, Clin Pharmacol Ther, 70, pp. 121-125, (2001)
[6]
Tracy T.S., Venkataramanan R., Glover D.D., Et al., Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy, Am J Obstet Gynecol, 192, pp. 633-639, (2005)
[7]
Yu T., Campbell S.C., Stockmann C., Et al., Pregnancy-induced changes in the pharmacokinetics of caffeine and its metabolites, J Clin Pharmacol, 56, pp. 590-596, (2016)
[8]
Tasnif Y., Morado J., Hebert M.F., Pregnancy-related pharmacokinetic changes, Clin Pharmacol Ther, 100, pp. 53-62, (2016)
[9]
Hakkola J., Pasanen M., Hukkanen J., Pelkonen O., Maenpaa J., Edwards R.J., Boobis A.R., Raunio H., Expression of xenobiotic-metabolizing cytochrome P450 Forms in human full-term placenta, Biochemical Pharmacology, 51, 4, pp. 403-411, (1996)
[10]
Bracken M.B., Triche E., Grosso L., Et al., Heterogeneity in assessing self-reports of caffeine exposure: Implications for studies of health effects, Epidemiology, 13, pp. 165-171, (2002)